Gout: Rising Prevalence and Incidence

MedicalResearch.com Interview with:
Weiya Zhang, BPH, MEpi, PhD
Associate Professor & Reader
Division of Rheumatology, Orthopaedics and Dermatology
The University of Nottingham
Clinical Sciences Building City Hospital
Nottingham NG5 1PB

MedicalResearch.com: What are the main findings of the study?

Dr. Zhang: We found the prevalence and incidence of gout keep rising from 1997 to 2012, but the management (percentage of patients treated with the recommended effective drugs) remains poor.

MedicalResearch.com: Were any of the findings unexpected?

Dr. Zhang: it is unexpected that the management of gout remains constantly poor (only a third receive proper treatment) irrespective of all national and international treatment guidelines published in the past decade.

MedicalResearch.com: What should clinicians and patients take away from your report?

Dr. Zhang: Gout is the prevalent condition affecting 1 in 40 people in the UK population.  The prevalence increased rapidly (4% per year) from 1997 to 2012.  It is one of a few medical conditions which have effective treatment, but unfortunately it has been poorly managed.

MedicalResearch.com: What recommendations do you have for future research as a result of this study?

Dr. Zhang: Research in the identification of the factors related to the poor management of gout and how to improve it would be very useful.


Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study

Kuo C-F, Grainge MJ, Mallen C, et al
Ann Rheum Dis Published Online First: 1/15/2013
doi:10.1136/annrheumdis- 2013-204463